Thermo Fisher Scientific Inc. (NEO: TMO)

Market Cap	288.09B
Revenue (ttm)	57.17B
Net Income (ttm)	8.28B
Shares Out	n/a
EPS (ttm)	21.53
PE Ratio	34.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,484
Open	19.26
Previous Close	19.21
Day's Range	19.26 - 19.56
52-Week Range	18.58 - 23.38
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 29, 2025

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 122,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: TMO

Financial Performance

In 2023, Thermo Fisher Scientific's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.

Financial numbers in USD